| Drug-Target Information | ||||||||
|---|---|---|---|---|---|---|---|---|
| Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
| ublituximab + umbralisib | leukocyte surface antigen leu-16 | NA | Successful target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Lymphoma Non-Hodgkin[MeSHID:D008228] Chronic Lymphocytic Leukemia[MeSHID:D015451] |
NA | phase 3 | unknown |
| click here to return to the previous page | ||||||||